Werewolf Therapeutics, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Werewolf Therapeutics, Inc.
- Company name
- Werewolf Therapeutics, Inc.
- Organisation type
- Industry
- Registered legal name
- Werewolf Therapeutics, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001785530
Related records
Trials (3)
- A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma
- Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
- WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma